Major Complication Rate in Cancer Patients With Neutropenic Fever Potentially Eligible for a Hospital at Home Program
Study Details
Study Description
Brief Summary
This study investigates the major complication rate in cancer patients potentially eligible for a hospital at home program for management of neutropenic fever. "Hospital at Home" is a home care program that provides acute, inpatient care in a patient's home in place of a traditional hospital stay. Learning more about the characteristics of potentially eligible patients, including reasons for inpatient admission, rates of major complications, and situations or treatments that would be difficult to deliver in an at home setting may help to inform future program development.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Detailed Description
PRIMARY OBJECTIVE:
- Estimate the major complication rate among patients potentially eligible for a hospital at home program for management of neutropenic fever.
SECONDARY OBJECTIVES:
-
Describe the demographic and clinical characteristics of patients potentially eligible for admission to a hospital at home program for management of neutropenic fever.
-
Describe situations or treatments experienced by potentially eligible patients admitted for neutropenic fever that would be difficult to accomplish in a hypothetical hospital at home program (e.g., blood transfusions, echocardiograms, computed tomography [CT] scans).
OUTLINE:
Patients' medical charts are reviewed.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Observational (chart review) Patients' medical charts are reviewed. |
Other: Medical Chart Review
Review of medical charts
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Percentage of patients who experience major complications that require escalated care [1 month]
Percentages will be presented with exact binomial 95% confidence interval. Also, will identify significant predictors of major complications (yes or no) using univariable logistic regression.
Secondary Outcome Measures
- Patient demographic, clinical, and psychosocial features [1 month]
Will describe the study sample demographic, clinical, and psychosocial features. Descriptors will include frequencies, percentages, means with standard deviations, or medians with interquartile ranges, and minimum and maximum values as appropriate.
- Situations or treatments experienced by potentially eligible patients admitted for neutropenic fever that would be difficult to accomplish in a hypothetical hospital at home (HaH) program [1 month]
Will enumerate situations and treatments observed in the study sample that could not be handled optimally in the HaH environment.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Admitted to MD Anderson Cancer Center through the Emergency Center with a diagnosis of neutropenic fever between 1/1/2019 and 12/31/2019
-
Be at low risk for major complications as defined by a Multinational Association for Supportive Care in Cancer (MASCC) score < 21
Exclusion Criteria:
-
Reside in a nursing home
-
Homelessness
-
Hospice enrollment
-
A secondary reason for admission to the hospital or high risk clinical feature not captured in the MASCC score that places them at high risk for major complications in a hospital at home program
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | M D Anderson Cancer Center | Houston | Texas | United States | 77030 |
Sponsors and Collaborators
- M.D. Anderson Cancer Center
- National Cancer Institute (NCI)
Investigators
- Principal Investigator: Tacara N Soones, M.D. Anderson Cancer Center
Study Documents (Full-Text)
None provided.More Information
Additional Information:
Publications
None provided.- 2020-0394
- NCI-2020-06606
- 2020-0394